Could Patient Stratification Help Lilly Finally Unlock An Alzheimer’s Breakthrough?

Tau Status Stratification Unique To Lilly Trial

Lilly believes its approach can help identify the Alzheimer’s patients who would benefit most from a beta amyloid clearing therapy – but skepticism about the mechanism itself remains widespread.

Eli Lilly logo sign atop Lilly Biotechnology Center
Lilly's TRAILBLAZER 2 will be the last of the three competitor trials to read out, in mid-2023. • Source: Michael Vi / Shutterstock.com

More from Business

More from Scrip